DarioHealth Corp.
DRIO · XNASCIK 1533998fmd_1419NYR6HEFGN09REMJ0BMK40DManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2012 to Sep 30, 2026, 59 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 3 | 5 | 7 | 8 | 8 | 21 | 28 | 20 | 27 | 22 |
| Cost of revenue | 3 | 4 | 6 | 5 | 5 | 17 | 18 | 14 | 14 | 10 |
| Gross profit | (1) | 1 | 2 | 3 | 3 | 4 | 10 | 6 | 13 | 13 |
| Research and development | 2 | 3 | 4 | 4 | 4 | 17 | 20 | 20 | 24 | 14 |
| Compensation and benefits | – | – | – | – | – | – | – | – | – | – |
| Total operating expenses | 10 | 16 | 19 | 20 | 32 | 80 | 66 | 62 | 71 | 49 |
| Operating income | (11) | (14) | (18) | (18) | (30) | (76) | (57) | (56) | (58) | (37) |
| Interest expense | – | – | – | – | – | – | 2 | – | – | 3 |
| Interest and investment income | – | – | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 1 |
| Other non-operating income (expense) | 0 | (1) | (0) | (0) | 0 | (0) | (5) | (3) | 13 | (5) |
| Income before taxes | (11) | (16) | (18) | (18) | (29) | (77) | (62) | (59) | (45) | (42) |
| Income tax expense | – | – | – | – | – | 0 | 0 | 0 | (2) | 0 |
| Net income from continuing operations | – | – | – | – | – | (77) | (62) | (59) | 43 | 42 |
| Net income | (11) | (16) | (18) | (18) | (29) | (77) | (62) | (59) | (43) | (42) |
| Net income to common shareholders | (12) | (16) | (18) | (21) | (33) | (68) | (60) | – | – | – |